Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Te — Bernhard Kuhn (UNIVERSITY O
ABSTRACT Right ventricular remodeling leads to serious complications in congenital heart disease. Congenital heart disease (CHD) is the most common birth defect. Due to improved diagnostics and surger
| Project title | Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Te |
|---|---|
| Project number | 5R01HL155597-02 |
| PI name | Bernhard Kuhn |
| Institution | UNIVERSITY OF PITTSBURGH AT PITTSBURGH |
| Funding mechanism | R01 |
| Agency | NHLBI |
| Award amount | $677,514 |
| Fiscal year | 2022 |
| Project start | 2021-07-01T00:00:00 |
| Project end | 2026-06-30T00:00:00 |
| Abstract | ABSTRACT Right ventricular remodeling leads to serious complications in congenital heart disease. Congenital heart disease (CHD) is the most common birth defect. Due to improved diagnostics and surger |
| Key terms | <0-11 years old><Academy><Active Follow-up><Age-Months><American><Arrhythmia><Birth><Birth Defects>< |
$799/mo
Try GrantRadar →